Myomo (MYO) Retained Earnings (2016 - 2025)
Myomo (MYO) posted Retained Earnings of $164517.0 for Q4 2025, up 100.14% on a QoQ basis from -$114.9 million in Q3 2025, and up 1242.0% year-over-year from $12259.1 in Q4 2024.
Myomo (MYO) Retained Earnings (2016 - 2025) Analysis & Trends
Myomo's Retained Earnings history runs 10 years deep, the most recent figure standing at $164517.0 for Q4 2025.
- Quarterly Retained Earnings rose 1242.0% year-over-year to $164517.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $164517.0 (up 1242.0% YoY) and the FY2025 annual result came in at $164517.0, up 1242.0% from the prior year.
- Retained Earnings was $164517.0 for Q4 2025 at Myomo, up from -$114.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $164517.0 in Q4 2025 and bottomed at -$114.9 million in Q3 2025.
- A 5-year average of -$68.9 million and a median of -$85.2 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings sank 1202313.57% — and 2025, when it jumped 1242.0%.
- Myomo's Retained Earnings stood at -$60677.0 in 2021, then plunged by 146221.08% to -$88.8 million in 2022, then decreased by 9.18% to -$96.9 million in 2023, then soared by 99.99% to -$14406.0 in 2024, then soared by 1242.0% to $164517.0 in 2025.
- Business Quant data shows MYO's Retained Earnings at $164517.0 in Q4 2025, -$114.9 million in Q3 2025, and -$111.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | 164,517.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 164,517.00 |
| Sep 30, 2025 | -114.87 Mn |
| Jun 30, 2025 | -111.21 Mn |
| Mar 31, 2025 | -106.58 Mn |
| Dec 31, 2024 | -14,406.00 |
| Sep 30, 2024 | -102.85 Mn |
| Jun 30, 2024 | -101.89 Mn |
| Mar 31, 2024 | 147,511.00 |
| Dec 31, 2023 | -96.93 Mn |
| Sep 30, 2023 | -8,554.00 |
| Jun 30, 2023 | -92.44 Mn |
| Mar 31, 2023 | -91.43 Mn |
| Dec 31, 2022 | -88.78 Mn |
| Sep 30, 2022 | -86.60 Mn |
| Jun 30, 2022 | -83.79 Mn |
| Mar 31, 2022 | -80.88 Mn |
| Dec 31, 2021 | -60,677.00 |
| Sep 30, 2021 | -75.30 Mn |
| Jun 30, 2021 | -73.27 Mn |
| Mar 31, 2021 | -70.65 Mn |